Skip to main content
Unichem Laboratories Ltd. logo

Unichem Laboratories Ltd. — Investor Relations & Filings

Ticker · UNICHEMLAB ISIN · INE351A01035 LEI · 3358008AHXLO9H4C2Q20 BSE.NS Manufacturing
Filings indexed 1,118 across all filing types
Latest filing 2025-01-07 Regulatory Filings
Country IN India
Listing BSE.NS UNICHEMLAB

About Unichem Laboratories Ltd.

https://www.unichemlabs.com/

Unichem Laboratories Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The company provides solutions across various therapeutic areas, including cardiology, gastroenterology, anti-infectives, diabetology, orthopedics, and neurology. It maintains a significant international footprint, exporting products to regulated markets such as the United States and Europe. The manufacturing infrastructure is built to comply with global standards, featuring approvals from international regulatory agencies. Through its dedicated research and development initiatives, the organization develops a robust pipeline of generic products and complex formulations aimed at improving patient outcomes globally.

Recent filings

Filing Released Lang Actions
Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018.
Regulatory Filings Classification · 95% confidence The document is a Compliance Certificate under regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2024. It is issued by the Registrar & Share Transfer Agent confirming compliance related to dematerialisation of securities and related processes. The document is addressed to stock exchanges and is a formal attestation of regulatory compliance rather than a financial report or announcement of financial results. It is short (2933 characters) and primarily a certification letter. According to the rules, such officer certifications or compliance confirmations should be classified as Regulatory Filings (RNS).
2025-01-07 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a short notification addressed to stock exchanges regarding a change in the name of the company's Registrar and Share Transfer Agent (RTA) due to an acquisition. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The document does not contain any financial data, report, or detailed analysis. It is an announcement of a corporate event (change in RTA name) rather than a financial report or detailed filing. The document length is only 1512 characters, indicating it is a brief announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-01-03 English
Intimation by Registrar & Transfer Agent (RTA) Change in name from Link Intime India Private Limited to MUFG Intime India Private Limited.
Regulatory Filings Classification · 95% confidence The document is a short notification addressed to stock exchanges regarding a change in the name of the company's Registrar and Share Transfer Agent (RTA) due to an acquisition. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The document does not contain financial data, management discussion, voting results, or any report itself. It is an announcement of a corporate event (change in RTA name) rather than a report or detailed filing. Given the nature and length of the document, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-01-03 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice regarding the closure of the trading window for insiders and designated persons in compliance with insider trading regulations. It references the upcoming financial results for the quarter and nine months ended December 31, 2024, but does not contain any financial data or results itself. The document is short (1309 characters) and serves as a regulatory announcement related to insider trading compliance rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-12-20 English
Intimation of closure of trading window.
Regulatory Filings Classification · 95% confidence The document is a notice regarding the closure of the trading window for insiders and designated persons in compliance with insider trading regulations. It references the upcoming financial results for the quarter and nine months ended December 31, 2024, but does not contain any financial data or results itself. The document is short (1309 characters) and serves as a regulatory announcement related to insider trading compliance rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-12-20 English
General Updates
Regulatory Filings
2024-12-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.